Cargando…
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia
Current treatment standards in psychiatry are oriented towards polypharmacy, that is, patients receive combinations of several antidepressants, antipsychotics, mood stabilizers, anxiolytics, hypnotics, antihistamines, and anticholinergics, along with other somatic treatments. In tandem with the bene...
Autores principales: | Stassen, H. H., Bachmann, S., Bridler, R., Cattapan, K., Herzig, D., Schneeberger, A., Seifritz, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095543/ https://www.ncbi.nlm.nih.gov/pubmed/34822007 http://dx.doi.org/10.1007/s00406-021-01358-5 |
Ejemplares similares
-
Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapy
por: Stassen, H. H., et al.
Publicado: (2020) -
Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disorders
por: Braun, Silke, et al.
Publicado: (2017) -
A two-center pilot study on the effects of clinical ethics support on coercive measures in psychiatry
por: Stoll, Julia, et al.
Publicado: (2022) -
Polypharmacy In Psychiatry: A Review
por: Kukreja, Sanjay, et al.
Publicado: (2013) -
Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry
por: Bortolasci, Chiara C, et al.
Publicado: (2018)